Future Health Esg Stock Current Valuation
| FHLTDelisted Stock | USD 10.37 0.00 0.00% |
Valuation analysis of Future Health Esg helps investors to measure Future Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Future Health's price fluctuation is very steady at this time. Calculation of the real value of Future Health Esg is based on 3 months time horizon. Increasing Future Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Future Health's intrinsic value may or may not be the same as its current market price of 10.37, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.37 | Real 8.77 | Hype 10.37 | Naive 10.34 |
The intrinsic value of Future Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Future Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Future Health Esg helps investors to forecast how Future stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Future Health more accurately as focusing exclusively on Future Health's fundamentals will not take into account other important factors: Future Health Esg Company Current Valuation Analysis
Future Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Future Health Current Valuation | 64.94 M |
Most of Future Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Future Health Esg is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Future Health Esg has a Current Valuation of 64.94 M. This is 99.8% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The current valuation for all United States stocks is 99.61% higher than that of the company.
Future Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Future Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Future Health could also be used in its relative valuation, which is a method of valuing Future Health by comparing valuation metrics of similar companies.Future Health is currently under evaluation in current valuation category among its peers.
Future Fundamentals
| Return On Asset | -0.0246 | ||||
| Current Valuation | 64.94 M | ||||
| Shares Outstanding | 5.94 M | ||||
| Shares Owned By Insiders | 75.53 % | ||||
| Shares Owned By Institutions | 22.70 % | ||||
| Number Of Shares Shorted | 68 | ||||
| Price To Book | 10.22 X | ||||
| EBITDA | (678.59 K) | ||||
| Net Income | (48.42 K) | ||||
| Cash And Equivalents | 962.01 K | ||||
| Cash Per Share | 0.04 X | ||||
| Current Ratio | 1.45 X | ||||
| Book Value Per Share | (1.73) X | ||||
| Cash Flow From Operations | (717.95 K) | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | -0.12 | ||||
| Market Capitalization | 65.06 M | ||||
| Total Asset | 17.23 M | ||||
| Retained Earnings | (10.28 M) | ||||
| Working Capital | (8.31 M) | ||||
| Net Asset | 17.23 M |
About Future Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Future Health Esg's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Future Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Future Health Esg based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Future Stock
If you are still planning to invest in Future Health Esg check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Future Health's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |